BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32698181)

  • 1. The Challenges of Using UK Renal Registry Data to Audit the Care of Patients with Diabetes on Renal Replacement Therapy.
    Cox L; Wong E; Evans KM; Medcalf J; Pyart R
    Nephron; 2020; 144(9):440-446. PubMed ID: 32698181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 4 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2009 to 2010.
    Shaw C; Webb L; Casula A; Tomson CR
    Nephron Clin Pract; 2012; 120 Suppl 1():c81-91. PubMed ID: 22964575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK Renal Registry 13th Annual Report (December 2010): Chapter 4: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2008 to 2009.
    Webb L; Gilg J; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c85-96. PubMed ID: 21894042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 13 The linkage of incident renal replacement therapy patients in England (2002-2006) to hospital episodes and national mortality data: improved demography and hospitalisation data in patients undergoing renal replacement therapy.
    Fotheringham J; Fogarty D; Jacques R; El Nahas M; Campbell M
    Nephron Clin Pract; 2012; 120 Suppl 1():c247-60. PubMed ID: 22964571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK Renal Registry 12th Annual Report (December 2009): chapter 6: comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2003 to 2008: national and centre-specific analyses.
    Caskey F; Webb L; Gilg J; Fogarty D
    Nephron Clin Pract; 2010; 115 Suppl 1():c103-16. PubMed ID: 20413944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK Renal Registry 16th annual report: chapter 5 comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland from 2011 to 2012.
    Rao A; Steenkamp R; Caskey F
    Nephron Clin Pract; 2013; 125(1-4):99-110. PubMed ID: 24662169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
    Shaw C; Simms RJ; Pitcher D; Sandford R
    Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UK Renal Registry 11th Annual Report (December 2008): Chapter 6 Comorbidities and current smoking status amongst patients starting renal replacement therapy in England, Wales and Northern Ireland: national and centre-specific analyses.
    Udayaraj U; Tomson CR; Gilg J; Ansell D; Fogarty D
    Nephron Clin Pract; 2009; 111 Suppl 1():c97-111. PubMed ID: 19542707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 10 Blood pressure profile of prevalent patients receiving renal replacement therapy in England, Wales and Northern Ireland in 2010: national and centre-specific analyses.
    Caskey F; Webb L; Pitcher D; Farrington K
    Nephron Clin Pract; 2012; 120 Suppl 1():c211-8. PubMed ID: 22964568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses.
    Gilg J; Rao A; Fogarty D
    Nephron Clin Pract; 2013; 125(1-4):1-27. PubMed ID: 24662165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 1 UK RRT incidence in 2010: national and centre-specific analyses.
    Gilg J; Castledine C; Fogarty D
    Nephron Clin Pract; 2012; 120 Suppl 1():c1-27. PubMed ID: 22964563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with diabetic nephropathy on renal replacement therapy in England and Wales.
    Nitsch D; Burden R; Steenkamp R; Ansell D; Byrne C; Caskey F; Roderick P; Feest T
    QJM; 2007 Sep; 100(9):551-60. PubMed ID: 17681992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UK Renal Registry 11th Annual Report (December 2008): Chapter 14 UK Renal Registry and international comparisons.
    Boddana P; Caskey F; Casula A; Ansell D
    Nephron Clin Pract; 2009; 111 Suppl 1():c269-76. PubMed ID: 19542702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 2 UK RRT prevalence in 2010: national and centre-specific analyses.
    Castledine C; Casula A; Fogarty D
    Nephron Clin Pract; 2012; 120 Suppl 1():c29-54. PubMed ID: 22964573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UK Renal Registry 13th Annual Report (December 2010): Chapter 11: blood pressure profile of prevalent patients receiving renal replacement therapy in England, Wales and Northern Ireland in 2009: national and centre-specific analyses.
    Webb L; Tomson CR; Casula A; Farrington K
    Nephron Clin Pract; 2011; 119 Suppl 2():c215-24. PubMed ID: 21894034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration.
    Hommel K; Rasmussen S; Madsen M; Kamper AL
    Nephrol Dial Transplant; 2010 Mar; 25(3):947-51. PubMed ID: 19861312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chapter 11 Clinical, haematological and biochemical parameters in patients receiving renal replacement therapy in paediatric centres in the UK in 2010: national and centre-specific analyses.
    Pruthi R; Maxwell H; Casula A; Tse Y; Sinha MD; O'Brien C; Lewis M; Inward C
    Nephron Clin Pract; 2012; 120 Suppl 1():c219-32. PubMed ID: 22964569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom.
    Iwagami M; Tomlinson LA; Mansfield KE; Casula A; Caskey FJ; Aitken G; Fraser SDS; Roderick PJ; Nitsch D
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii142-ii150. PubMed ID: 28201668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy and end-stage renal failure: the Norwegian story.
    Bergrem H; Leivestad T
    Adv Ren Replace Ther; 2001 Jan; 8(1):4-12. PubMed ID: 11172323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).
    Van Dijk PC; Jager KJ; Stengel B; Grönhagen-Riska C; Feest TG; Briggs JD
    Kidney Int; 2005 Apr; 67(4):1489-99. PubMed ID: 15780102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.